Day Patrick L, Rokke Denise, Schneider Laura, Abbott Jillian, Holmen Brenda, Johnson Patrick, Wieczorek Mikolaj A, Kunze Katie L, Carter Rickey E, Bornhorst Joshua, Jannetto Paul J
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.
J Appl Lab Med. 2025 Mar 3;10(2):305-314. doi: 10.1093/jalm/jfae146.
We sought to evaluate key performance indicators related to an internally developed and deployed artificial intelligence (AI)-augmented kidney stone composition test system for potential improvements in test quality, efficiency, cost-effectiveness, and staff satisfaction.
We compared quality, efficiency, staff satisfaction, and financial data from the 6 months after the AI-augmented laboratory test system was deployed (test period) with data from the same 6-month period in the previous year (control period) to determine if AI-augmentation improved key performance indicators of this laboratory test.
In the 6 months following the deployment (test period) of the AI-augmented kidney stone composition test system, 44 830 kidney stones were analyzed. Of these, 92% of kidney stones were eligible for AI-assisted interpretation. Out of these AI-eligible stones, 45% were able to be auto-released by the AI-augmented test system without human secondary review. Furthermore, the new AI-augmented kidney stone test system resulted in an apparent 40% reduction in incorrect laboratory results. Additionally, the new AI-augmented test system improved laboratory efficiency by 20%, improved staff satisfaction, and reduced the average analysis cost per kidney stone by $0.23.
The AI-augmented test system improved test quality, efficiency, cost-effectiveness and staff satisfaction related to this kidney stone composition test.
我们试图评估与内部开发和部署的人工智能(AI)增强型肾结石成分检测系统相关的关键绩效指标,以在检测质量、效率、成本效益和员工满意度方面实现潜在改进。
我们将AI增强型实验室检测系统部署后6个月(测试期)的质量、效率、员工满意度和财务数据与上一年同一6个月期间(对照期)的数据进行比较,以确定AI增强是否改善了该实验室检测的关键绩效指标。
在AI增强型肾结石成分检测系统部署后的6个月(测试期)内,共分析了44830颗肾结石。其中,92%的肾结石符合AI辅助解读条件。在这些符合AI条件的结石中,45%能够由AI增强检测系统自动发布,无需人工二次审核。此外,新的AI增强型肾结石检测系统使错误实验室结果明显减少了40%。此外,新的AI增强型检测系统提高了实验室效率20%,提高了员工满意度,并使每颗肾结石的平均分析成本降低了0.23美元。
AI增强型检测系统改善了与该肾结石成分检测相关的检测质量、效率、成本效益和员工满意度。